Results
1
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
1 companies
OSE Immunotherapeutics
Market Cap: €125.3m
A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.
OSE
€5.59
7D
4.9%
1Y
-37.0%